Concepedia

Analyses of Efficacy End Points in a Controlled Trial of Interferon-γ1b for Idiopathic Pulmonary Fibrosis

Talmadge E. King, Sharon Safrin, Karen M. Starko, Kevin K. Brown, Paul W. Noble, Ganesh Raghu, David A. Schwartz

CHEST Journal · 2005 · 223 citations · 7 references

DOI

Concepts

References

7

Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis

Harold R. Collard, Talmadge E. King, Becki Bucher Bartelson et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 762 citations

, , +17

Statistical Problems in the Reporting of Clinical Trials

Stuart Pocock, Michael D. Hughes, Robert J. Lee · New England Journal of Medicine · 1987 · 671 citations

, , +14

A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

Ganesh Raghu, Kevin K. Brown, Williamson Z. Bradford et al. · New England Journal of Medicine · 2004 · 652 citations · Full text

, , +15

A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis

Rolf Ziesche, Elisabeth Hofbauer, Karin Wittmann et al. · New England Journal of Medicine · 1999 · 592 citations · Full text

, , +17

Fibrotic Idiopathic Interstitial Pneumonia

P. Latsi, Roland M. du Bois, Andrew G. Nicholson et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 584 citations

, , +17